HCM
DGX icon

Herndon Capital Management’s Quest Diagnostics DGX Stock Holding History

Herndon Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-13
Closed -$1K – 298
2016
Q3 		$1K Hold
13
– – ﹤0.01% 442
2016
Q2 		$1K Buy
+13
New +$990 ﹤0.01% 459

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Herndon Capital Management's DGX Position: Q4 2016 in Review

Herndon Capital Management sold out of Quest Diagnostics (DGX) in Q4 2016, closing a stake of 13 shares — an estimated $1K sold.

Herndon Capital Management first reported a position in DGX in Q2 2016 and held it in 2 quarters. The position peaked at $1K in Q3 2016. 598 funds tracked by Wall St. Rank hold DGX as of Q4 2016.

  • Herndon Capital Management reported no remaining Quest Diagnostics position as of Q4 2016 after selling out during the quarter.
  • Herndon Capital Management sold 13 Quest Diagnostics shares in Q4 2016, an estimated $1K.
  • Herndon Capital Management first reported a position in Quest Diagnostics in Q2 2016 and held it in 2 quarters.
  • Herndon Capital Management's Quest Diagnostics position peaked at $1K in Q3 2016.
  • 598 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2016.

Based on Herndon Capital Management's 13F filing for Q4 2016, filed 2 Feb 2017.